Low dose of oral alendronate decreases bone turnover in Japanese patients with Paget’s disease of bone


Paget’s disease of bone is a disorder showing chronic abnormality of bone turnover. Paget’s disease is common in Europe, North America, Australia, and New Zealand, but is rare in Asia [1]. Alendronate, one of the bisphosphonates, is now widely used for the treatment of Paget’s disease, and numerous studies have demonstrated the efficacy of alendronate for… (More)
DOI: 10.1007/s00774-005-0609-4

2 Figures and Tables


  • Presentations referencing similar topics